AJG vs BBNX · P/E 33, rev $8.76B vs rev $100.3M
Arthur J Gallagher & Co (AJG) versus Beta Bionics, Inc. Common Stock (BBNX) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. BBNX currently screens at market cap $640.8M.
Not investment advice. Open the AJG and BBNX stock pages for the full models.
Not investment advice.